Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease - PubMed (original) (raw)
Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease
B J Cummings et al. Neurobiol Aging. 1996 Nov-Dec.
Abstract
The relationship between progressive cognitive decline and underlying neuropathology associated with Alzheimer s disease (AD) is a key issue in defining the mechanisms responsible for functional loss. This has been a subject of much controversy, with separate studies comparing various clinical and neuropathological indices in AD. Further, it is difficult to compare studies with differences in histochemical staining protocols, brain regions examined, and data quantification criteria. There are many difficulties in designing a clinical-pathological correlative study involving AD patients. It is necessary to control for several key parameters. For example, a broad range of cognitively impaired subjects is needed, as well as short postmortem delays, brief intervals between cognitive testing and death, and the most sensitive detection and quantification techniques. In this study, we carefully controlled for each of these parameters to determine if there is a relationship between global cognitive dysfunction and multiple neuropathological indices. We selected 20 individuals representing a broad range of cognitive ability from normal to severely impaired based on the MMSE, Blessed IMC, and CDR. We counted plaque number, NFT number, dystrophic neurite number, and the relative extent of thioflavine positive plaques and neuritic involvement within plaques. We also quantified cortical area occupied by beta-amyloid immunoreactivity (A beta Load) and PHF-1 positive neuropil threads and tangles (PHF Load) using computer-based image analysis. Interestingly, we found that most pathologic measures correlated highly with the severity of dementia. However, the strongest predictor of premortem cognitive dysfunction on all three cognitive measures was the relative area of entorhinal cortex occupied by beta-amyloid deposition. In conclusion, our data show that in a carefully controlled correlative study, a variety of neuropathological variables are strongly correlated with cognitive impairment. Plaque related variables may be as strongly related to cognitive dysfunction as other established measures, including synapse loss, cell death and tau hyperphosphorylation, although no correlative study can demonstrate causality.
Comment in
- Disentangling a complex pattern of interrelationships among multiple measures of Alzheimer neuropathology and clinical status: comments on Cummings, Pike, Shankle, and Cotman.
Silverman W, Bobinski M, Wisniewski HM. Silverman W, et al. Neurobiol Aging. 1996 Nov-Dec;17(6):933-5; discussion 945-7. doi: 10.1016/s0197-4580(96)00172-8. Neurobiol Aging. 1996. PMID: 9363805 No abstract available. - Senile cerebral amyloidosis (pathological aging) and cognitive status predictions: a neuropathology perspective.
Dickson DW. Dickson DW. Neurobiol Aging. 1996 Nov-Dec;17(6):936-7; discussion 945-7. doi: 10.1016/s0197-4580(96)00173-x. Neurobiol Aging. 1996. PMID: 9363806 No abstract available. - Alzheimer's disease pathogenesis: the challenge of establishing dynamic biological processes from static measurements.
Greenberg BD. Greenberg BD. Neurobiol Aging. 1996 Nov-Dec;17(6):938-9; discussion 945-7. doi: 10.1016/s0197-4580(96)00175-3. Neurobiol Aging. 1996. PMID: 9363807 No abstract available. - Neuropathological markers of impaired cognition in the entorhinal cortex.
Hyman BT, Gomez-Isla T. Hyman BT, et al. Neurobiol Aging. 1996 Nov-Dec;17(6):940-1; discussion 945-7. doi: 10.1016/s0197-4580(96)00174-1. Neurobiol Aging. 1996. PMID: 9363808 No abstract available. - The cellular and molecular correlates of cognitive impairments in the Alzheimer's disease brain.
Trojanowski JQ. Trojanowski JQ. Neurobiol Aging. 1996 Nov-Dec;17(6):941-3; discussion 945-7. doi: 10.1016/s0197-4580(96)00176-5. Neurobiol Aging. 1996. PMID: 9363809 No abstract available. - On keys and correlations in Alzheimer's disease.
Potter H. Potter H. Neurobiol Aging. 1996 Nov-Dec;17(6):943-4; discussion 945-7. doi: 10.1016/s0197-4580(96)00177-7. Neurobiol Aging. 1996. PMID: 9363810 No abstract available.
Similar articles
- Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.
Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Litchfield S, Smith A, Barnetson L, Smith AD. Nagy Z, et al. Dementia. 1995 Jan-Feb;6(1):21-31. doi: 10.1159/000106918. Dementia. 1995. PMID: 7728216 - Activation of caspase-6 in aging and mild cognitive impairment.
Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC. Albrecht S, et al. Am J Pathol. 2007 Apr;170(4):1200-9. doi: 10.2353/ajpath.2007.060974. Am J Pathol. 2007. PMID: 17392160 Free PMC article. - Neuropathology of Alzheimer's disease: a critical update.
Jellinger KA, Bancher C. Jellinger KA, et al. J Neural Transm Suppl. 1998;54:77-95. doi: 10.1007/978-3-7091-7508-8_8. J Neural Transm Suppl. 1998. PMID: 9850917 Review. - Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
Yilmazer-Hanke DM, Hanke J. Yilmazer-Hanke DM, et al. Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):70-6. doi: 10.1159/000017104. Dement Geriatr Cogn Disord. 1999. PMID: 10026378 Clinical Trial. - Neuropathological changes in aging brain.
Xekardaki A, Kövari E, Gold G, Papadimitropoulou A, Giacobini E, Herrmann F, Giannakopoulos P, Bouras C. Xekardaki A, et al. Adv Exp Med Biol. 2015;821:11-7. doi: 10.1007/978-3-319-08939-3_6. Adv Exp Med Biol. 2015. PMID: 25416106 Review.
Cited by
- AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning.
Fan S, Ponisio MR, Xiao P, Ha SM, Chakrabarty S, Lee JJ, Flores S, LaMontagne P, Gordon B, Raji CA, Marcus DS, Nazeri A, Ances BM, Bateman RJ, Morris JC, Benzinger TLS, Sotiras A; Alzheimer's Disease Neuroimaging Initiative. Fan S, et al. Radiology. 2024 Jun;311(3):e231442. doi: 10.1148/radiol.231442. Radiology. 2024. PMID: 38860897 - Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice.
Zhang N, Sui Y, Jendrichovsky P, Feng H, Shi H, Zhang X, Xu S, Sun W, Zhang H, Chen X, Tortorella MD, He J. Zhang N, et al. Alzheimers Res Ther. 2024 May 15;16(1):109. doi: 10.1186/s13195-024-01472-1. Alzheimers Res Ther. 2024. PMID: 38750512 Free PMC article. - Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer's disease.
Lin HC, Lin KJ, Huang KL, Chen SH, Ho TY, Huang CC, Hsu JL, Chang CC, Hsiao IT. Lin HC, et al. Front Neurosci. 2023 May 12;17:1148054. doi: 10.3389/fnins.2023.1148054. eCollection 2023. Front Neurosci. 2023. PMID: 37250400 Free PMC article. - Ependyma in Neurodegenerative Diseases, Radiation-Induced Brain Injury and as a Therapeutic Target for Neurotrophic Factors.
Ma XY, Yang TT, Liu L, Peng XC, Qian F, Tang FR. Ma XY, et al. Biomolecules. 2023 Apr 27;13(5):754. doi: 10.3390/biom13050754. Biomolecules. 2023. PMID: 37238624 Free PMC article. Review. - Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.
Lilek J, Ajroud K, Feldman AZ, Krishnamachari S, Ghourchian S, Gefen T, Spencer CL, Kawles A, Mao Q, Tranovich JF, Jack CR, Mesulam MM, Reichard RR, Zhang H, Murray ME, Knopman D, Dickson DW, Petersen RC, Smith B, Ashe KH, Mielke MM, Nelson KM, Flanagan ME. Lilek J, et al. J Alzheimers Dis. 2023;92(1):241-260. doi: 10.3233/JAD-220848. J Alzheimers Dis. 2023. PMID: 36744338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical